Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessMustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) Earnings Report Highlights

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) Earnings Report Highlights

Add to Favorite
Added to Favorite


Earnings per Share (EPS) of -0.02, surpassing the estimated EPS of -0.03.
Reported revenue was approximately $206,329.46, in line with expectations.
Positive financial indicators include a low debt-to-equity ratio of 0.14 and a current ratio of 4.87.

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) is a company focused on developing and selling biological solutions for agriculture. Its flagship product, TerraSante, is a biofertility product aimed at enhancing crop yields. The company operates in a competitive market, with other players also offering innovative agricultural solutions. MGROF trades on the PNK exchange.
On November 26, 2024, MGROF reported its earnings, revealing an earnings per share (EPS) of -0.02, which surpassed the estimated EPS of -0.03. The company’s revenue was approximately $206,329.46, aligning with expectations. This performance reflects the initial revenue from TerraSante sales, which amounted to C$279,000, including C$272,000 in deferred revenue.
Despite a negative price-to-earnings (P/E) ratio of -209.88, MGROF’s financial metrics show some positive aspects. The debt-to-equity ratio is low at 0.14, indicating limited reliance on debt. Additionally, the current ratio of 4.87 suggests a strong ability to meet short-term obligations, providing a cushion for the company as it navigates its growth phase.
Analysts at Noble Capital are optimistic about MGROF’s future, projecting a significant increase in TerraSante sales for 2025. They expect fourth-quarter revenue to be around C$25,000, with a target of C$625,000 for fiscal 2025. This growth is anticipated as the company secures more state approvals, expanding its market reach.
The enterprise value to sales ratio of 18.00 and the price-to-sales ratio of 18.88 indicate that investors are willing to pay a premium for MGROF’s sales, reflecting confidence in its growth potential. However, the enterprise value to operating cash flow ratio is significantly negative at -453.31, highlighting challenges in generating cash flow.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Ulta Beauty Boosts Full-Year Outlook, Stock Rises 9 percent

Ulta Beauty (NASDAQ:ULTA) raised its full-year 2024 outlook, capitalizing...

Samsara Surpasses Q3 Expectations but Slowing Revenue Growth Weighs on Shares

Samsara (NYSE:IOT) delivered third-quarter results that exceeded Wall Street's...

Hewlett Packard Enterprise Surpasses Q4 Expectations with Record Revenue, Shares Gain 9 percent

Hewlett Packard Enterprise (NYSE:HPE) saw its shares climb over...

GitLab Posts Strong Q3 Results, Upbeat Guidance, and Leadership Change

GitLab (NASDAQ:GTLB) delivered strong fiscal third-quarter results, issued optimistic...